Predict your next investment

Shoreline company logo
INTERNET | Internet Software & Services / Collaboration & Project Management
shoreline.no

See what CB Insights has to offer

Founded Year

2014

Stage

Seed VC | Alive

Total Raised

$4.2M

Last Raised

$4M | 2 yrs ago

About Shoreline

Shoreline provides web based, user-friendly, verified and proven simulation software and consulting for the offshore wind industry. The software can assist developers, OEMs, financial institutions, insurance companies, vessel owners and service providers in general in analyzing the entire offshore wind project life cycle from early project assessment until decommission, and thus reduce risk and subsequent cost of energy significantly. Shoreline takes pride in maintaining a high level of integrity and professionalism, and offer clients tailor made simulation solutions and consultancy services matching the individual needs of the clients.

Shoreline Headquarter Location

Bryggerikaien 16

Stavanger, NO-4014,

Norway

Latest Shoreline News

Gilead combs Shoreline for NK cell therapies in $2.3bn alliance

Jun 18, 2021

June 18, 2021 Gilead Sciences’ cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off-the-shelf therapies for haematological cancers. The two companies will collaborate on the development of targeted NK cell and macrophage cells derived from induced pluripotent stem cells (iPSC), cementing a relationship that has already seen Kite invest in Shoreline’s first-round financing, which raised $43 million in April. It’s the second deal in a matter of days for Shoreline, coming after China’s BeiGene paid $45 million upfront to harvest the San Diego-based biotech’s iPSC platform to develop NK cell therapies for cancer. Kite is making an undisclosed upfront payment and is on the hook for up to $2.3 billion in additional milestones if the projects all come to fruition. NK cells are emerging as a potentially safer and more convenient alternative to the current generation of CAR-T cell therapies – which include Gilead/Kite’s Yescarta (axicabtagene ciloleucel) and Tecartus (brexucabtagene autoleucel). Shoreline’s approach of developing off-the-shelf (allogeneic) cell therapies – which don’t require the convoluted and time-consuming harvesting, modification and reinfusion of patient-derived cells with the current generation of CAR-Ts – could allow patients to get treatment more quickly and cheaply, and be re-dosed if necessary. The company is also hopeful that its approach could extend the use of cell-based immunotherapy for cancer to solid tumours, something that has so far eluded CAR-Ts based on T cells, and may reduce the serious side effects that limit the use of CAR-Ts like cytokine release syndrome (CRS). T cells are part of the adaptive immune system, so need to be activated before they attack cancer cells that present antigens. NK cells are part of the innate immune system, a first line of defense that doesn’t need to be primed into action. The latest collaboration will focus initially on NK therapies for leukaemia and lymphoma indications, with an option to expand the collaboration to include a macrophage-based therapy for an undisclosed target later on. Kite will contribute its expertise in cell therapy development, commercialisation and manufacturing to the alliance. Shoreline’s founder and chief executive Kleanthis Xanthopoulos said the deal will “potentially accelerate Shoreline’s timeline to the clinic, expand our pipeline opportunities and deliver transformational treatment options for cancer.” The biotech was founded to develop technology discovered in the labs of NK biology specialist Dan Kaufman and immunology researcher Bill Sandborn at the University of California San Diego (UCSD). NK cell therapy is fast developing into a busy field, so it’s something of a coup for Shoreline to forge an alliance with an established player like Gilead/Kite. Other companies working in the NK area include oNKo-innate – also working with Gilead/Kite – as well as Nkarta, Fate Therapeutics, Artiva, Dragonfly Therapeutics, Kiadis, and Catamaran Bio. Don't miss your daily pharmaphorum news.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Shoreline

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Shoreline is included in 2 Expert Collections, including Renewable Energy.

R

Renewable Energy

72 items

Startups developing technology to help offshore wind farm operators minimize costs and optimize production. These startups are enabling real-time turbine inspection and monitoring, as well as wind measurement and forecasting to help improve wind farm profitability.

F

Fintech

4,558 items

Track and capture company information and workflow.

Shoreline Patents

Shoreline has filed 16 patents.

The 3 most popular patent topics include:

  • Wireless networking
  • Database management systems
  • Free database management systems
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/18/2020

10/26/2021

Wireless networking, Virtual private networks, Computer network security, Network protocols, Digital subscriber line

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/18/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/26/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Wireless networking, Virtual private networks, Computer network security, Network protocols, Digital subscriber line

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Shoreline Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Shoreline Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.